TLDR BlackRock’s Bitcoin ETF aims to generate yield via covered call options. The ETF will primarily invest in spot Bitcoin and Bitcoin-linked assets. SEC review process underway for BlackRock’s Bitcoin Premium Income ETF. BlackRock’s ETF provides an income-focused approach to Bitcoin investment. Nasdaq has officially filed with the U.S. Securities and Exchange Commission (SEC) to [...] The post Nasdaq Files with SEC to List BlackRock Bitcoin Premium Income ETF appeared first on CoinCentral.TLDR BlackRock’s Bitcoin ETF aims to generate yield via covered call options. The ETF will primarily invest in spot Bitcoin and Bitcoin-linked assets. SEC review process underway for BlackRock’s Bitcoin Premium Income ETF. BlackRock’s ETF provides an income-focused approach to Bitcoin investment. Nasdaq has officially filed with the U.S. Securities and Exchange Commission (SEC) to [...] The post Nasdaq Files with SEC to List BlackRock Bitcoin Premium Income ETF appeared first on CoinCentral.

Nasdaq Files with SEC to List BlackRock Bitcoin Premium Income ETF

2025/10/01 20:27
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • BlackRock’s Bitcoin ETF aims to generate yield via covered call options.
  • The ETF will primarily invest in spot Bitcoin and Bitcoin-linked assets.
  • SEC review process underway for BlackRock’s Bitcoin Premium Income ETF.
  • BlackRock’s ETF provides an income-focused approach to Bitcoin investment.

Nasdaq has officially filed with the U.S. Securities and Exchange Commission (SEC) to list the BlackRock iShares Bitcoin Premium Income ETF. This new exchange-traded fund (ETF) aims to provide income through Bitcoin-linked strategies by utilizing covered call options. If approved, it could offer investors an innovative way to generate yield from Bitcoin while reducing volatility, marking another major step in integrating cryptocurrency with traditional investment products.

BlackRock Bitcoin Premium Income ETF Overview

The BlackRock iShares Bitcoin Premium Income ETF is set to be listed on Nasdaq, pending approval from the SEC. This filing, made on September 30, introduces a product focused on generating income through covered call options on Bitcoin.

Unlike typical Bitcoin ETFs, which track the spot price of Bitcoin, this ETF uses a strategy designed to yield consistent returns through option sales. The ETF will primarily invest in spot Bitcoin and Bitcoin-linked assets such as IBIT.

The filing highlights the potential for BlackRock’s new fund to appeal to income-focused investors who are looking for a way to generate returns from Bitcoin exposure without directly holding the volatile cryptocurrency. The ETF will use covered calls to provide additional income, which could help offset some of the price fluctuations of Bitcoin itself.

How It Differs from the BlackRock Bitcoin ETF (IBIT)

While BlackRock’s previous Bitcoin ETF, the iShares Bitcoin ETF (IBIT), aims to track Bitcoin’s spot price, the new Bitcoin Premium Income ETF has a distinct approach. The Premium Income ETF will use a covered call strategy, where it writes call options on Bitcoin-linked products, particularly IBIT or indices that track Bitcoin. This strategy seeks to generate income from the premiums collected on the options, which is different from merely holding Bitcoin assets.

The move indicates BlackRock’s strategy to expand its suite of crypto-linked products rather than diversifying into altcoins or other digital assets. The Premium Income ETF will also include cash and other liquid assets to provide flexibility in managing its investments, as well as the option to invest in exchange-listed FLEX options.

SEC’s Role and Approval Process

Following Nasdaq’s filing, the SEC acknowledged that the BlackRock iShares Bitcoin Premium Income ETF meets the necessary criteria under its General Listing Standards. However, the commission has also opened the floor for public comments regarding the proposed rule changes for the ETF.

The process could take several months, as the SEC reviews any feedback and considers whether the ETF meets all regulatory requirements before approving it for trading.

The SEC’s involvement in this process is a crucial step in ensuring that the ETF complies with the standards set for commodity-based trust products. Once the ETF receives approval, it will be available for trading on Nasdaq, providing investors with a new way to gain exposure to Bitcoin without directly owning the digital asset.

Potential Impact on Bitcoin and Crypto Markets

If the SEC approves the BlackRock Bitcoin Premium Income ETF, it could further bridge the gap between traditional finance and the cryptocurrency market. By offering a Bitcoin-based ETF that focuses on income generation, BlackRock is positioning itself to attract investors who may have been hesitant to enter the highly volatile Bitcoin market.

The use of covered calls as a strategy could appeal to risk-conscious investors who seek stability and consistent returns.

At press time, Bitcoin is holding steady above $114,000, but the broader crypto market has experienced some volatility. BlackRock’s product could serve as an alternative investment for those looking to hedge against Bitcoin’s price fluctuations while still gaining exposure to its potential upside.

The proposed ETF could also pave the way for future crypto-linked investment products, further solidifying the role of Bitcoin in mainstream financial markets.

The post Nasdaq Files with SEC to List BlackRock Bitcoin Premium Income ETF appeared first on CoinCentral.

Market Opportunity
Octavia Logo
Octavia Price(VIA)
$0.0015488
$0.0015488$0.0015488
-1.64%
USD
Octavia (VIA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09